Literature DB >> 1430140

An evaluation of couples with failure of fertilization in vitro.

T E Coates1, J H Check, J Choe, K Nowroozi, D Lurie, C Callan.   

Abstract

Attempts at in-vitro fertilization (IVF) may be used as a method of evaluating whether in a given couple, the inability of the sperm to fertilize the oocyte may be the cause of infertility. We evaluated all IVF patients in our practice who had at least one cycle with no fertilization to determine how often this was an isolated event or was repeated in multiple cycles; would poor semen quality be found as a frequent cause; and how well can a donor sperm or oocyte 'probe' uncover which of the two is the problem? Of 35 couples who used their own gametes exclusively, 30 (85.7%) had at least one cycle with zero fertilization; 42.5% of those failing to fertilize in cycle 1 and 35% of those failing in cycle 2 had a subnormal concentration of motile spermatozoa, morphology or hypo-osmotic swelling test scores. The pregnancy rate per cycle with both husband's and wife's gametes was only 2.3% (3/130), but was 8.3% for those using donor spermatozoa (3/36) and 18.2% (2/11) for donor oocytes. Thus, failing to fertilize in a given cycle does not necessarily predict failure to fertilize in a subsequent cycle, but does predict a poor fertility outcome unless donor gametes are used.

Entities:  

Mesh:

Year:  1992        PMID: 1430140     DOI: 10.1093/oxfordjournals.humrep.a137783

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

Review 1.  Male factor infertility and ART.

Authors:  Herman Tournaye
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

2.  Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial.

Authors:  Danni Zheng; Lin Zeng; Rui Yang; Ying Lian; Yi-Min Zhu; Xiaoyan Liang; Li Tang; Huichun Wang; Yunxia Cao; Guimin Hao; Jianqiao Liu; Junli Zhao; Rui Wang; Ben Willem Mol; Rong Li; He-Feng Huang; Jie Qiao
Journal:  BMJ Open       Date:  2019-09-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.